On Tuesday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) opened higher 12.77% from the last session, before settling in for the closing price of $1.41. Price fluctuations for SLS have ranged from $0.77 to $2.48 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 45.94% over the last five years. Company’s average yearly earnings per share was noted 46.00% at the time writing. With a float of $142.08 million, this company’s outstanding shares have now reached $142.44 million.
SELLAS Life Sciences Group Inc (SLS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SELLAS Life Sciences Group Inc is 0.26%, while institutional ownership is 23.23%. The most recent insider transaction that took place on Jun 12 ’25, was worth 14,800. In this transaction Director of this company bought 10,000 shares at a rate of $1.48, taking the stock ownership to the 20,400 shares. Before that another transaction happened on May 30 ’25, when Company’s Director bought 20,000 for $1.69, making the entire transaction worth $33,800. This insider now owns 30,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.08 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.11) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.72% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Check out the current performance indicators for SELLAS Life Sciences Group Inc (SLS). In the past quarter, the stock posted a quick ratio of 8.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Analysing the last 5-days average volume posted by the [SELLAS Life Sciences Group Inc, SLS], we can find that recorded value of 4.12 million was better than the volume posted last year of 2.81 million. As of the previous 9 days, the stock’s Stochastic %D was 27.60%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 18.35%, which indicates a significant decrease from 27.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1209 in the past 14 days, which was lower than the 0.1293 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7787, while its 200-day Moving Average is $1.6020. Now, the first resistance to watch is $1.6921. This is followed by the second major resistance level at $1.7942. The third major resistance level sits at $1.9384. If the price goes on to break the first support level at $1.4458, it is likely to go to the next support level at $1.3016. Now, if the price goes above the second support level, the third support stands at $1.1995.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are currently 142,442K shares outstanding in the company with a market cap of 226.48 million. Presently, the company’s annual sales total 0 K according to its annual income of -30,880 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,790 K.
